跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG
Approved
STANDARD
PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG
Brillpharma (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 15, 2021
Approval ID
ac8f6ca2291cd95a
Company
Brillpharma (Ireland) Limited
Type
Standard
Approval Details
Approval Id
ac8f6ca2291cd95a
Drug Cima Aemps Name
PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG
Register Number
84171
Holder Company Name
Brillpharma (Ireland) Limited
Marketing Company Name
Brillpharma (Ireland) Limited
Authorization Date
2021-02-15
Dosage Form
SOLUCIÓN ORAL
Dose
20 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Brillpharma (Ireland) Limited
Active Ingredients
PREGABALINA
20 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 15, 2021
Approval ID
ac8f6ca2291cd95a
Type
Standard
Back to CIMA-AEMPS Approvals
